|
RU2566713C1
|
|
Means for treatment and prevention of sleep disorders
|
|
RU2574001C1
|
|
Medication for treating and prevention of alcoholism
|
|
RU2538611C1
|
|
Method of determining biological inequivalence of nanodiamonds
|
|
RU2542411C1
|
|
Conjugate of nanodiamond with pyrophosphatase and method of obtaining thereof
|
|
RU2519760C1
|
|
Antioxidant and method for preparing it
|
|
RU2519759C1
|
|
Antidepressant drug and method for preparing it
|
|
RU2506074C1
|
|
Antihypoxant and method for preparing it
|
|
RU2519761C1
|
|
Antipsychotic agent and method for preparing it
|
|
RU2506075C1
|
|
Sedative agent and method for preparing it
|
|
RU2508098C1
|
|
Anticonvulsant and method for preparing it
|
|
RU2519755C1
|
|
Anxiolytic and method for preparing it
|
|
RU2521404C1
|
|
Agent with anti-stroke action, and method for preparing it
|
|
RU2506095C1
|
|
Method for selective final purification of nanodiamond
|
|
RU2198171C2
|
|
Novel crystalline modification of 5-fluoro-1-(tetrahydro-2-furyl)-uracil and complex compounds based on thereof exhibiting antitumor effect
|
|
RU94040242A
|
|
Method of tuberculosis treatment
|
|
RU2044545C1
|
|
Method for amplifying antitumoral effect of experimental radiotherapy
|
|
RU2034543C1
|
|
Antitumor remedy
|
|
RU2063226C1
|
|
Method for activating alveolar macrophages
|
|
RU2061476C1
|
|
Composition showing antimicrobial effect
|
|
RU2061472C1
|
|
Composition showing antimicrobial effect
|
